ID/[reference] | Gene/Locus | Disease/Outcome | SNPs in haplotype | Number of studies | Significant results | Fixed effects | Random effects | |||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | β = 0 (summary data) | β = 0 (IPD) | γ = 0 (IPD) | β = 0 (summary data) | β = 0 (IPD) |
2/[98] | ITGAV | Rheumatoid Arthritis | 3 | 3 | Yes$$ | 0.2506 | 0.2489 | 0.1564 | 0.3288 | 0.3851 |
5/[99] | CX3CR1 | CAD | 2 | 6 | Yes$ | 0.0834* | 0.0677* | 0.6263 | 0.0883* | 0.1031* |
16/[94] | CTLA4 | Graves Disease | 2 | 10 | Yes | <0.0001 | <0.0001 | 0.0371 | <0.0001 | <0.0001 |
17/[94] | CTLA4 | Hashimoto Thyroiditis | 2 | 5 | Yes | 0.0011 | 0.0010 | <0.0001 | 0.0044 | 0.0072 |
20/[97] | CAPN10 | T2DM | 3 | 11 | Yes$$ | 0.1152 | 0.1036 | 0.6145 | 0.2243 | 0.1655 |
21/[93] | ADAM33 | Asthma | 5 | 3 | No | 0.6209 | 0.5508 | 0.4697 | 0.6134 | 0.5503 |
26/[78] | VDR | Osteoporosis | 3 | 4 | Yes$$ | 0.1458 | 0.3051 | <0.0001 | 0.1480 | 0.5781 |
27/[95] | ACE | Alzheimer's Disease | 3 | 4 | Yes | 0.0193 | 0.0218 | 0.8906 | 0.0193 | 0.0223 |
30/[92] | FcgammaR | Celliac Disease | 2 | 2 | No | 0.7331 | 0.7335 | 0.9502 | 0.7331 | 0.7336 |
32/[96] | G72/G30 | Schizophrenia | 2 | 2 | Yes$$ | 0.7790 | 0.7757 | 0.0001 | 0.5750 | 0.6719 |
33/[68] | VEGF | ALS | 3 | 4 | Yes$ | 0.0437* | 0.0414 | 0.0691 | 0.0716 | 0.0455* |
39/[91] | TNFA | Prostate Cancer | 5 | 2 | No | 0.2531 | 0.2515 | 0.6185 | 0.2867 | 0.2511 |
40/[90] | PTGS2 | Prostate Cancer | 4 | 2 | No | 0.3560 | 0.3550 | 0.2087 | 0.6573 | 0.4829 |